Posted opportunity — confirm at source
DoW Vision, Clinical Trial Award
Defense Health Agency Contracting Activity - DHACA · HT942526VRPCTA
See source for award amount
2026-11-12-00-00-00
Confirm exact timezone in the announcement.Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Geographic eligibility and all attachment-specific conditions require review of the original announcement.
Matching funds & resources
Source matching-funds field: Not Required.
Matching funds and leveraged resources are different requirements. Read the description and reviewed rules below before determining resource commitments.
About this opportunity
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Research must align with at least one of the FY26 VRP Focus Areas . Distinctive Features: · For interventions that require Investigational New Drug (IND)/Investigational Device Exemption (IDE) or equivalent regulatory authorizations for clinical testing, the IND/IDE application or equivalent must be submitted to the relevant Regulatory Agency by the CTA application submission deadline. In addition, applicants must provide documentation of communication from the Regulatory Agency indicating that the IND/IDE or equivalent is active/safe to proceed by March 1, 2027, in order for the CTA application to be considered for funding. Refer to Attachment 7: Regulatory Strategy for further details. · Scored peer review criteria include Clinical Impact; Research Strategy and Feasibility; Recruitment, Accrual, Retention; Regulatory Strategy and Transition Plan; Statistical Plan and Data Analysis; Ethical Considerations; Personnel and Communication. · Programmatic review criteria include adherence to the intent of the CTA, contribution to program portfolio, relative impact and relevance to military health. https://cdmrp.health.mil/pubs/press/2026/vrppreann
Funding geography: Not specified — review source. A funder’s address does not establish eligibility.
Review original source ↗Funding instrument: Grant. Issuing jurisdiction: Federal. This is not a geographic eligibility determination.
Source fields and evidence
id: 362183
Source ↗ · id
opportunityNumber: HT942526VRPCTA
Source ↗ · opportunityNumber
opportunityTitle: DoW Vision, Clinical Trial Award
Source ↗ · opportunityTitle
revision: 3
Source ↗ · revision
agencyDetails: {"code":"AMRAA","seed":"DOD-AMRAA","agencyName":"Defense Health Agency Contracting Activity - DHACA","agencyCode":"DOD-AMRAA","topAgencyCode":"DOD"}
Source ↗ · agencyDetails
owningAgencyCode: DOD-AMRAA
Source ↗ · owningAgencyCode
cfdas: [{"id":433047,"opportunityId":362183,"cfdaNumber":"12.420","programTitle":"Military Medical Research and Development"}]
Source ↗ · cfdas
applicantTypes: [{"id":"99","description":"Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled \"Additional Information on Eligibility\""}]
Source ↗ · applicantTypes
fundingInstruments: [{"id":"G","description":"Grant"}]
Source ↗ · fundingInstruments
fundingActivityCategories: [{"id":"ST","description":"Science and Technology and other Research and Development"}]
Source ↗ · fundingActivityCategories
awardFloor: none
Source ↗ · awardFloor
awardCeiling: none
Source ↗ · awardCeiling
responseDate: Nov 12, 2026 12:00:00 AM EST
Source ↗ · responseDate
responseDateStr: 2026-11-12-00-00-00
Source ↗ · responseDateStr
costSharing: false
Source ↗ · costSharing
lastUpdatedDate: May 05, 2026 09:51:33 AM EDT
Source ↗ · lastUpdatedDate
status: posted
Source ↗ · oppHits[id=362183].oppStatus
Related collections: Research funding opportunities · Defense health research funding ·
Build your funding pipeline.
Save opportunities, filter by fit, and export your deadlines with membership.
View plans from $49/month ↗